Discussion regarding botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Minimal risk of antibody formation after aesthetic treatment with type a botulinum toxin.
Discussion regarding botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications.
Pickett
Andy
A
andy.pickett@ipsen.com
Caird
David
D
D000917:Antibody Formation; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000737:chemistry / Q000276:immunology*; D003357:Cosmetic Techniques; D006801:Humans; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000737:chemistry / Q000276:immunology*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A